• Viewed 10,240 times by 3014 users (Last 30 days)
  • print Created with Sketch. Print

Corporate Spotlight
Not Yet Available

Are you a Company Director ?
Put your Investment Case to Hotcopper's 700K monthly unique visitors.

Announcements


Plus500
Plus500
ANNOUNCEMENT SPONSORED BY PLUS500
ANNOUNCEMENT SPONSORED BY PLUS500
CFD TRADING PLATFORM
CFD Service. Your Capital is at risk
CFD TRADING PLATFORM CFD Service. Your Capital is at risk
Plus500
ANNOUNCEMENT SPONSORED BY PLUS500
CFD TRADING PLATFORM CFD Service. Your Capital is at risk

Filters [Clear]
  • Price Sensitive: Yes
BPO +Update on Legal dispute with Solagran LimitedPRICE SENSITIVE27/10/10
BPORights Issue ProspectusPRICE SENSITIVE26/10/10
BPOTermilone Project UpdatePRICE SENSITIVE22/10/10
BPOShare Placement, Appendix 3B and Righst IssuePRICE SENSITIVE19/10/10
BPOBioProspect secures alternative CGNC supplyPRICE SENSITIVE20/09/10
BPO +Dispute with Solagran LimitedPRICE SENSITIVE06/09/10
BPOPreliminary Final ReportPRICE SENSITIVE31/08/10
BPO +Update on dispute with Solagran LimtedPRICE SENSITIVE13/08/10
BPOAppendix 4C - quarterlyPRICE SENSITIVE30/07/10
BPOTermilone trials updatePRICE SENSITIVE30/06/10
BPO +Bioeffectives Project with BioProspect LimitedPRICE SENSITIVE28/06/10
BPOTrading HaltPRICE SENSITIVE25/06/10
BPOGI-GUARD horse treatment submitted for regulatory approvalPRICE SENSITIVE11/06/10
BPOAGRIPRO natural animal health products updatePRICE SENSITIVE31/05/10
BPOUpdate on Re Gen Wellness productsPRICE SENSITIVE25/05/10
BPOTermilone commercialisation updatePRICE SENSITIVE21/05/10
BPO2010 Share Purchase Plan -Issue price and termsPRICE SENSITIVE12/05/10
BPOShare Placement and Appendix 3BPRICE SENSITIVE30/04/10
BPOAnnouncement of Share Purchase PlanPRICE SENSITIVE30/04/10
BPOAppendix 4C - quarterlyPRICE SENSITIVE29/04/10
BPOTermilone CSIRO Field Trial resultsPRICE SENSITIVE23/04/10
BPOBioProspect announces successful horse safety studiesPRICE SENSITIVE30/03/10
BPOHalf Yearly Report and AccountsPRICE SENSITIVE25/02/10
BPO +BioProspect and Solagran agreement to commercialisePRICE SENSITIVE25/02/10
BPOReinstatement to Official QuotationPRICE SENSITIVE25/02/10
BPOSuspension from Official QuotationPRICE SENSITIVE25/02/10
BPOTrading HaltPRICE SENSITIVE22/02/10
BPOAPVMA approval for TERMILONEPRICE SENSITIVE08/02/10
BPOAppendix 4C - quarterlyPRICE SENSITIVE29/01/10
BPOPlacementPRICE SENSITIVE28/01/10
BPOQcide Intellectual Property AgreementPRICE SENSITIVE19/01/10
BPOTermilone market development agreement with EnsystexPRICE SENSITIVE24/12/09
BPOAppendix 4C - quarterlyPRICE SENSITIVE30/10/09
BPOResponse to ASX Price and Volume QueryPRICE SENSITIVE19/10/09
BPOPreliminary Final ReportPRICE SENSITIVE28/08/09
BPOAppendix 4C - quarterlyPRICE SENSITIVE30/07/09
BPOAgreement to acquire Re-Gen Wellness ProductsPRICE SENSITIVE29/07/09
BPOTermilone registration update with APVMAPRICE SENSITIVE09/07/09
BPOBioprospect signs Option to purchase Re-GenPRICE SENSITIVE07/05/09
BPOAppendix 4C - quarterlyPRICE SENSITIVE28/04/09
BPOHalf Year Report and AccountsPRICE SENSITIVE24/02/09
BPOAppendix 4C - quarterlyPRICE SENSITIVE29/01/09
BPOEnsystex evaluation agreement for TermilonePRICE SENSITIVE12/01/09
BPO +Update on Legal dispute with Solagran Limited
27/10/10PRICE SENSITIVE
BPORights Issue Prospectus
26/10/10PRICE SENSITIVE
BPOTermilone Project Update
22/10/10PRICE SENSITIVE
BPOShare Placement, Appendix 3B and Righst Issue
19/10/10PRICE SENSITIVE
BPOBioProspect secures alternative CGNC supply
20/09/10PRICE SENSITIVE
BPO +Dispute with Solagran Limited
06/09/10PRICE SENSITIVE
BPOPreliminary Final Report
31/08/10PRICE SENSITIVE
BPO +Update on dispute with Solagran Limted
13/08/10PRICE SENSITIVE
BPOAppendix 4C - quarterly
30/07/10PRICE SENSITIVE
BPOTermilone trials update
30/06/10PRICE SENSITIVE
BPO +Bioeffectives Project with BioProspect Limited
28/06/10PRICE SENSITIVE
BPOTrading Halt
25/06/10PRICE SENSITIVE
BPOGI-GUARD horse treatment submitted for regulatory approval
11/06/10PRICE SENSITIVE
BPOAGRIPRO natural animal health products update
31/05/10PRICE SENSITIVE
BPOUpdate on Re Gen Wellness products
25/05/10PRICE SENSITIVE
BPOTermilone commercialisation update
21/05/10PRICE SENSITIVE
BPO2010 Share Purchase Plan -Issue price and terms
12/05/10PRICE SENSITIVE
BPOShare Placement and Appendix 3B
30/04/10PRICE SENSITIVE
BPOAnnouncement of Share Purchase Plan
30/04/10PRICE SENSITIVE
BPOAppendix 4C - quarterly
29/04/10PRICE SENSITIVE
BPOTermilone CSIRO Field Trial results
23/04/10PRICE SENSITIVE
BPOBioProspect announces successful horse safety studies
30/03/10PRICE SENSITIVE
BPOHalf Yearly Report and Accounts
25/02/10PRICE SENSITIVE
BPO +BioProspect and Solagran agreement to commercialise
25/02/10PRICE SENSITIVE
BPOReinstatement to Official Quotation
25/02/10PRICE SENSITIVE
BPOSuspension from Official Quotation
25/02/10PRICE SENSITIVE
BPOTrading Halt
22/02/10PRICE SENSITIVE
BPOAPVMA approval for TERMILONE
08/02/10PRICE SENSITIVE
BPOAppendix 4C - quarterly
29/01/10PRICE SENSITIVE
BPOPlacement
28/01/10PRICE SENSITIVE
BPOQcide Intellectual Property Agreement
19/01/10PRICE SENSITIVE
BPOTermilone market development agreement with Ensystex
24/12/09PRICE SENSITIVE
BPOAppendix 4C - quarterly
30/10/09PRICE SENSITIVE
BPOResponse to ASX Price and Volume Query
19/10/09PRICE SENSITIVE
BPOPreliminary Final Report
28/08/09PRICE SENSITIVE
BPOAppendix 4C - quarterly
30/07/09PRICE SENSITIVE
BPOAgreement to acquire Re-Gen Wellness Products
29/07/09PRICE SENSITIVE
BPOTermilone registration update with APVMA
09/07/09PRICE SENSITIVE
BPOBioprospect signs Option to purchase Re-Gen
07/05/09PRICE SENSITIVE
BPOAppendix 4C - quarterly
28/04/09PRICE SENSITIVE
BPOHalf Year Report and Accounts
24/02/09PRICE SENSITIVE
BPOAppendix 4C - quarterly
29/01/09PRICE SENSITIVE
BPOEnsystex evaluation agreement for Termilone
12/01/09PRICE SENSITIVE
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.